If it is a short enough time, it is not going to be worth the amount of money that the manufacturer--well, they are not manufacturers; they are more like what I would call hedge fund pharmaceutical companies--would pay to get the rights to that drug.
Discussing the impact of expedited drug approvals on pharmaceutical companies' pricing strategies.
Share & report
More from Susan Collins
I'm still looking at it because it kept changing up until literally the very minute it passed.
Maine’s Susan Collins has expressed 'concern' about cuts to forest and park services, as well as to research institutes.
I will continue to fight for federal funding for the state while also being against transgender athletes in biological female sports.
Other voices in this conversation
